HIV: current opinion in escapology

被引:77
作者
Klenerman, P [1 ]
Wu, Y [1 ]
Phillips, R [1 ]
机构
[1] Univ Oxford, Oxford OX1 3SY, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
D O I
10.1016/S1369-5274(02)00339-9
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Much recent work strongly supports the hypothesis that CD8(+) T lymphocytes (CTLs) exert important immune control over HIV and so are a major selective force in its evolution. We analyse this host-pathogen interplay and focus on new data that describe the overall 'effectiveness' of CTL responses (strength, spread, specificity and 'stamina') and the mechanisms by which HIV may evade this suppressive activity. CTLs directed against HIV recognise very large numbers of distinct epitopes across the genome, are largely functional, turn over rapidly, and possess a phenotype that is distinct from CD8(+) lymphocytes specific for other viruses. Mutation of HIV epitopes that alters or abolishes CTL recognition altogether appears to be the most important immune escape mechanism, as the variation that HIV generates defies the limits of the T cell repertoire. However, this immune evasion is still only well-studied in a few patients. The rules that govern immune escape, and the ultimate limits of CTL capacity to deal with the variant epitopes that currently circulate, are not understood. This information will determine the feasibility of current vaccine approaches that, so far, make no provision for the enormous antigenic plasticity of HIV.
引用
收藏
页码:408 / 413
页数:6
相关论文
共 52 条
  • [1] The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals
    Addo, MM
    Altfeld, M
    Rosenberg, ES
    Eldridge, RL
    Philips, MN
    Habeeb, K
    Khatri, A
    Brander, C
    Robbins, GK
    Mazzara, GP
    Goulder, PJR
    Walker, BD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) : 1781 - 1786
  • [2] Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
    Allen, TM
    Vogel, TU
    Fuller, DH
    Mothé, BR
    Steffen, S
    Boyson, JE
    Shipley, T
    Fuller, J
    Hanke, T
    Sette, A
    Altman, JD
    Moss, B
    McMichael, AJ
    Watkins, DI
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (09) : 4968 - 4978
  • [3] CD8+ lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule Mamu-A*01:: Implications for vaccine design and testing
    Allen, TM
    Mothé, BR
    Sidney, J
    Jing, PC
    Dzuris, JL
    Liebl, ME
    Vogel, TU
    O'Connor, DH
    Wang, XC
    Wussow, MC
    Thomson, JA
    Altman, JD
    Watkins, DI
    Sette, A
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (02) : 738 - 749
  • [4] Vpr is preferentially targeted by CTL during HIV-1 infection
    Altfeld, M
    Addo, MM
    Eldridge, RL
    Yu, XG
    Thomas, S
    Khatri, A
    Strick, D
    Phillips, MN
    Cohen, GB
    Islam, SA
    Kalams, SA
    Brander, C
    Goulder, PJR
    Rosenberg, ES
    Walker, BD
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (05) : 2743 - 2752
  • [5] Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
    Appay, V
    Dunbar, PR
    Callan, M
    Klenerman, P
    Gillespie, GMA
    Papagno, L
    Ogg, GS
    King, A
    Lechner, F
    Spina, CA
    Little, S
    Havlir, DV
    Richman, DD
    Gruener, N
    Pape, G
    Waters, A
    Easterbrook, P
    Salio, M
    Cerundolo, V
    McMichael, AJ
    Rowland-Jones, SL
    [J]. NATURE MEDICINE, 2002, 8 (04) : 379 - 385
  • [6] HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function
    Appay, V
    Nixon, DF
    Donahoe, SM
    Gillespie, GMA
    Dong, T
    King, A
    Ogg, GS
    Spiegel, HML
    Conlon, C
    Spina, CA
    Havlir, DV
    Richman, DD
    Waters, A
    Easterbrook, P
    McMichael, AJ
    Rowland-Jones, SL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) : 63 - 75
  • [7] Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys
    Barouch, DH
    Craiu, A
    Kuroda, MJ
    Schmitz, JE
    Zheng, XX
    Santra, S
    Frost, JD
    Krivulka, GR
    Lifton, MA
    Crabbs, CL
    Heidecker, G
    Perry, HC
    Davies, ME
    Xie, H
    Nickerson, CE
    Steenbeke, TD
    Lord, CI
    Montefiori, DC
    Strom, TB
    Shiver, JW
    Lewis, MG
    Letvin, NL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) : 4192 - 4197
  • [8] Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes
    Barouch, DH
    Kunstman, J
    Kuroda, MJ
    Schmitz, JE
    Santra, S
    Peyerl, FW
    Krivulka, GR
    Beaudry, K
    Lifton, MA
    Gorgone, DA
    Montefiori, DC
    Lewis, MG
    Wolinsky, SM
    Letvin, NL
    [J]. NATURE, 2002, 415 (6869) : 335 - 339
  • [9] Skewed maturation of memory HIV-specific CD8 T lymphocytes
    Champagne, P
    Ogg, GS
    King, AS
    Knabenhans, C
    Ellefsen, K
    Nobile, M
    Appay, V
    Rizzardi, GP
    Fleury, S
    Lipp, M
    Förster, R
    Rowland-Jones, S
    Sékaly, RP
    McMichael, AJ
    Pantaleo, G
    [J]. NATURE, 2001, 410 (6824) : 106 - 111
  • [10] CD4+ T-cell-epitope escape mutant virus selected in vivo
    Ciurea, A
    Hunziker, L
    Martinic, MMA
    Oxenius, A
    Hengartner, H
    Zinkernagel, RM
    [J]. NATURE MEDICINE, 2001, 7 (07) : 795 - 800